Advanced Biomed Inc. (ADVB)
NasdaqCM: ADVB
· Echtzeitkurs · USD
7.60
-0.17 (-2.19%)
Zum Schluss: Aug 12, 2026, 3:59 PM
Advanced Biomed Inc. (ADVB) Stock Price, Analysis & Data
-2.19% (1D)
| Geld | 5.99 |
| Marktkapitalisierung | 12.56 Mio |
| Umsatz (TTM) | n/a |
| Nettogewinn (TTM) | 4.76 Mio |
| Beta | n/a |
| EPS (ttm) | 3.85 |
| KGV (TTM) | 1.97 |
| Forward-KGV | n/a |
| KBV (TTM) | 1.14 |
| KUV (TTM) | n/a |
| Earnings Date | n/a |
| Brief | 9.6 |
| Volumen | 649,863 |
| Ø Vol. (20D) | 1,738,948 |
| Eröffnung | 8.10 |
| Vortagesschluss | 7.77 |
| Tagesspanne | 7.22 - 8.50 |
| 52-Wk Range | 3.61 - 24.23 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über ADVB
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a c...
Branche Diagnostics & Research
Sektor Healthcare
IPO Datum Mar 6, 2025
Mitarbeiter 31
Börse NasdaqCM
Tickersymbol ADVB
Website https://www.advanbiomed.com
Finanzielle Entwicklung
Im Jahr 2024 betrug der Umsatz von Advanced Biomed 0, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei -2.78 Mio, ein Rückgang von -25.46 %.
Finanzberichte